Sign in

CIK 0001425205 · Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
753254381
Phone
6502607120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
  1. 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,467 shares (to pay taxes)
  2. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 22,127 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Medical Officer gave up 6,448 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Operating Officer gave up 6,250 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 4,464 shares (to pay taxes)
  6. 4 Open-market buy Chief Regulatory Officer bought 5,600 shares at $1.74 ($9,743)
  7. 4 Open-market buy Interim CEO & General Counsel bought 25,000 shares at $1.69 ($42,250)
  8. 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,509 shares (to pay taxes)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 31,734 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Operating Officer gave up 33,302 shares (to pay taxes)
  16. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 95,413 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Regulatory Officer gave up 19,984 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Medical Officer gave up 33,470 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 4 of 18 · 352 filings